ChartRow logo
HR
$17.76+3.02%
as of close, Oct 20, 2026
☾ AH $17.76 +3.02%
PeersOHIDOCVTRWELLFRTEGP
Share this page

HR financial statements

The full income statement, balance sheet, and cash-flow statement for Healthcare Realty Trust Incorporated (HR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 363.0M2024-09 354.4M2024-12 350.8M2025-03 351.4M2025-06 351.6M2025-09 351.6M2025-12 348.8M2026-03 346.5M2026-06 342.7M-5.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.18B-6.9%1.27B-5.6%1.34B+44.1%933M+74.4%535M+7.0%
Lease income1.14B-7.7%1.23B-5.8%1.31B+44.3%907M+74.4%520M+5.7%
Selling, general & administrative72.6M-12.7%83.1M+42.3%58.4M+10.8%52.7M+54.4%34.2M+11.2%
General & administrative72.6M-12.7%83.1M+42.3%58.4M+10.8%52.7M+54.4%34.2M+11.2%
Amortization of intangibles113M-32.7%168M-21.9%215M+60.8%134M+296.4%33.7M
Provision for credit losses———0.000.00-100.0%
Interest expense209M-13.8%242M-6.2%259M+76.3%147M+176.1%53.1M-5.4%
Interest & investment income
————3.15M+471.7%
Other non-operating income-3.56M-1267.3%-260K-119.4%1.34M+186.9%-1.55M-17077.8%-9.00K-101.6%
Equity-method income-188K-39.3%-135K+92.0%-1.68M-144.8%-687K+13.6%-795K-71.7%
-246M+62.4%-654M-135.2%-278M-780.4%40.9M-38.6%66.7M-7.7%
Income from continuing operations———38.5M-40.4%64.5M-8.0%
Net income to non-controlling interest-3.41M+63.8%-9.42M-146.4%-3.82M-1773.5%-204K0.00
-$0.71+60.8%-$1.81-144.6%-$0.74-593.3%$0.15-66.7%$0.45-13.5%
EPS (basic)-$0.71+60.8%-$1.81-144.6%-$0.74-593.3%$0.15-66.7%$0.45-13.5%
Weighted-avg shares (basic)350M-4.3%366M-3.5%379M+50.2%252M+76.9%143M+6.5%
Weighted-avg shares (diluted)350M-4.3%366M-3.5%379M+49.3%254M+77.9%143M+6.5%
Dividends per share$1.10-11.3%$1.24+0.0%$1.24+0.0%$1.24+2.5%$1.21+0.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash & equivalents26.2M-62.0%68.9M+168.2%25.7M-57.8%61.0M+362.7%13.2M-88.6%
9.21B-13.5%10.7B-15.7%12.6B-8.8%13.8B+225.2%4.26B-37.3%
Operating lease right-of-use205M-21.6%261M-5.3%276M-18.1%337M+162.5%128M-45.4%
Goodwill—0.00-100.0%251M+12.2%223M+6301.0%3.49M
Intangible assets
————212M-10.9%
4.53B-15.2%5.35B-6.5%5.71B-7.4%6.17B+197.4%2.07B-41.7%
Long-term debt3.91B-16.1%4.66B-6.6%4.99B-6.7%5.35B+197.1%1.80B-40.5%
Operating lease liability (total)163M-27.4%224M-2.3%230M-17.9%280M+191.1%96.1M-51.5%
Finance lease liability (total)73.1M+1.1%72.3M-2.9%74.5M+2.1%72.9M+223.4%22.6M+189.8%
4.62B-11.8%5.23B-23.3%6.82B-9.9%7.57B+246.5%2.19B+12.2%
Preferred stock0.000.000.000.000.00
Common stock3.52M+0.3%3.50M-8.0%3.81M+0.1%3.81M+152.9%1.50M-31.2%
Additional paid-in capital9.14B+0.2%9.12B-5.0%9.60B+0.2%9.59B+141.3%3.97B-19.2%
Accumulated other comprehensive income
————-7.04M+58.5%
Non-controlling interest56.5M-14.7%66.2M-31.2%96.3M-11.5%109M0.00-100.0%
Total equity incl. non-controlling4.67B-11.8%5.30B-23.4%6.92B-9.9%7.68B+251.5%2.19B+12.2%
Total liabilities & equity9.21B-13.5%10.7B-15.7%12.6B-8.8%13.8B+225.2%4.26B-37.3%
Common shares issued352M+0.3%351M-8.0%381M+0.1%381M+153.0%150M-31.2%
Common shares outstanding352M+0.3%351M-8.0%381M+0.1%381M+153.0%150M-31.2%
Shares outstanding (cover)349M-0.6%351M-8.0%381M+0.1%381M+66.3%229M+4.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
457M-8.9%502M+0.4%500M+83.3%273M+17.2%233M-50.5%
Depreciation & amortization564M-16.5%675M-7.6%731M+61.3%453M+123.5%203M+6.4%
Intangible amortization113M-32.7%168M-21.9%215M+60.8%134M+296.4%33.7M
Share-based compensation22.4M-29.7%31.8M+122.7%14.3M-29.8%20.3M+89.6%10.7M+8.1%
711M-21.1%901M+158.0%349M-78.6%1.63B+390.6%-562M-1.3%
Capital expenditure330M+32.6%249M+7.8%231M+41.3%164M+68.3%97.2M+30.0%
Free cash flow127M-49.8%253M-6.0%269M+146.1%109M-19.4%135M-65.7%
Acquisitions0.000.000.000.000.00
-1.21B+10.9%-1.36B-53.7%-884M+52.4%-1.86B-667.4%328M+228.6%
Long-term debt issued0.000.000.000.000.00-100.0%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.00-100.0%104K-20.0%130K-99.4%22.9M-93.1%331M+133.2%
Common stock repurchased4.01M-54.9%8.88M+286.5%2.30M-28.0%3.19M-16.1%3.80M+164.8%
Dividends paid387M-15.5%458M-3.0%472M+66.5%284M+61.7%175M+7.9%
Net change in cash-42.7M-198.9%43.2M+222.6%-35.3M-173.8%47.8M+2345.6%-2.13M-114.5%
Interest paid177M-12.8%203M-6.3%216M+91.7%113M+127.9%49.4M-6.3%
Income taxes paid1.26M-29.7%1.79M+35.0%1.32M-27.8%1.83M+227.5%560K+0.5%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap5.91B-0.6%5.95B-9.4%6.56B-10.5%7.33B+1.2%7.25B+11.9%
P/E———74.6×-31.3%108.7×+21.2%
P/S5.0×+6.8%4.7×-3.5%4.9×-51.6%10.0×-26.0%13.5×+4.6%
P/B1.3×+12.7%1.1×+21.2%0.9×-1.3%0.9×-71.4%3.3×-0.2%
P/FCF46.6×+97.9%23.5×-27.9%32.6×-39.7%54.1×+1.2%53.5×+226.6%
Earnings yield———1.3%+45.7%0.92%-17.5%
FCF yield2.1%-49.5%4.2%+38.7%3.1%+65.8%1.8%-1.2%1.9%-69.4%
Dividend yield6.5%-11.3%7.3%+1.7%7.2%+11.8%6.4%+68.3%3.8%-5.7%
Source filing10-K10-K10-K10-K10-K

About this data

Source: HR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HR filings on SEC EDGAR → Not investment advice.